Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue?
- PMID: 29268468
- PMCID: PMC5721004
- DOI: 10.21037/jtd.2017.10.25
Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.J Am Coll Cardiol. 2017 Jun 6;69(22):2710-2720. doi: 10.1016/j.jacc.2017.03.578. J Am Coll Cardiol. 2017. PMID: 28571635 Free PMC article.
References
-
- Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2017. [Epub ahead of print]. - PubMed
-
- Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315. 10.1093/eurheartj/ehv320 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources